Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT03264456
Eligibility Criteria:
Inclusion Criteria:
\- High-risk biopsy-proven treatment-naïve prostate adenocarcinoma (Gleason score ≥ 8 and/or serum PSA \> 20)
Exclusion Criteria:
* Inability to tolerate or undergo PET/MRI
* Previous or current hematologic or lymphatic disorder (including leukemia, lymphoma, Castleman's disease, etc.)
* Recurrent prostate adenocarcinoma
* Known visceral, osseous, or extrapelvic metastases prior to fluciclovine-PET/MRI
* Known allergy to glucagon or gadolinium-based contrast
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03264456
Study Brief:
Protocol Section:
NCT03264456